0341 GMT - Life360 has the flexibility to manage potential dilution from its convertible note offering, MS analysts say. They tell clients that the tracking-app provider's raise strengthens its balance sheet through to fiscal 2030 at a very attractive rate. The trade-off is potential dilution if the dual-listed company's U.S. stock passes US$122.22 a share. They think that the structure of the notes and the strength of performance that would be required for the stock to trade at such levels provide Life360 with options to manage the scenario. MS has an overweight recommendation and A$32.00 target price on Life360's Australia-listed shares, which are down 1.7% at A$32.675. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
June 09, 2025 23:41 ET (03:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。